Relevant bibliographies by topics / Platelet-rich fibrin

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Platelet-rich fibrin'

Author: Grafiati
Published: 4 June 2021
Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Platelet-rich fibrin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Platelet-rich fibrin"

1

Avinash, Shashant, Gaurav Malhotra, Pradeep Shukla, and Prerna Kataria. "Autologous platelet rich fibrin." Asian Pacific Journal of Health Sciences 5, no. 3 (July 2018): 1–10. http://dx.doi.org/10.21276/apjhs.2018.5.3.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Murray, Taryn, and Shilpi Khetarpal. "Platelet-Rich Fibrin." Advances in Cosmetic Surgery 5, no. 1 (May 2022): 9–16. http://dx.doi.org/10.1016/j.yacs.2021.12.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tuţă, Alexandra Mihaela, Valentin Daniel Sîrbu, Ioan Sîrbu, and Ştefan Nichita. "Platelet rich fibrin (PRF) in oral implantology. Case study." Romanian Journal of Stomatology 61, no. 4 (December 31, 2015): 271–76. http://dx.doi.org/10.37897/rjs.2015.4.3.

Full text
Abstract:
Dental implant therapy based on osseointegration has known a big expansion in dentistry in the last years. Dental implant rehabilitation is a common procedure in restoring partial or total edentulous pacients in our days. A problem regarding implant rehabilitation appears when the pacient doesn’t have enought bone to allow implant insertion in safety conditions. In this cases the clinician has to turn to complementary interventions in order to improve bone width and height so that implants could be inserted. One of the most known procedures is guided bone regeneration (GBR – guided bone regeneration) wich consists in placing a membrane to the bone defects. Platelet rich fibrin (PRF – platelet rich fibrin) is a second generation platelet concentrate wich gives the clinician access to growth factors throught a simple and up to date technology. These growth factors wich are autologous, non-toxic and non-immunogenic enhance and accelerate normal bone regeneration pathways. (1)
APA, Harvard, Vancouver, ISO, and other styles
4

Katta, Prashanth Kumar. "Platelet Rich Plasma & Platelet Rich Fibrin: Dental Applications." Indian Journal of Contemporary Dentistry 4, no. 1 (2016): 44. http://dx.doi.org/10.5958/2320-5962.2016.00010.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Vokurka, J., E. Gopfert, M. Blahutkova, E. Buchalova, and M. Faldyna. "Concentrations of growth factors in platelet-rich plasma and platelet-rich fibrin in a rabbit model." Veterinární Medicína 61, No. 10 (October 21, 2016): 567–70. http://dx.doi.org/10.17221/24/2016-vetmed.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jasmine, Sharmila, Annamalai Thangavelu, Rajapandiyan Krishnamoorthy, KhalidE Alzahrani, and MohammadA Alshuniaber. "Architectural and ultrastructural variations of human leukocyte-rich platelet-rich fibrin and injectable platelet-rich fibrin." Journal of Microscopy and Ultrastructure 9, no. 2 (2021): 76. http://dx.doi.org/10.4103/jmau.jmau_7_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gundawar, Satwik Sham, Sudhindra Baliga, Nilima Thosar, and Nilesh Rathi. "Platelet Rich Fibrin in Dentistry." Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425) 4, no. 3 (March 31, 2018): 01–12. http://dx.doi.org/10.53555/nnmhs.v4i3.611.

Full text
Abstract:
Platelet rich fibrin (PRF) is a fibrin matrix in which platelet cytokines, growth factors and cells are trapped and may be released after a certain time and that can serve as a resorbable membrane. In the present review article, the evolution, preparation of PRF has been described. Autologous PRF is considered to be a healing biomaterial, which has its numerous applications in various disciplines of dentistry.
APA, Harvard, Vancouver, ISO, and other styles
8

B, UthappaK, BSJagadish pai, AmitK W, and Sreelakshmi sekhar. "PLATELET-RICH FIBRIN: A REVIEW." International Journal of Advanced Research 5, no. 11 (November 30, 2017): 677–81. http://dx.doi.org/10.21474/ijar01/5819.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kumar, Yuvika Raj, Sujata Mohanty, Mahesh Verma, Raunaq Reet Kaur, Priyanka Bhatia, Varun Raj Kumar, and Zainab Chaudhary. "Platelet-rich fibrin: the benefits." British Journal of Oral and Maxillofacial Surgery 54, no. 1 (January 2016): 57–61. http://dx.doi.org/10.1016/j.bjoms.2015.10.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mohamed, Shahana C. "Platelet-Rich Fibrin: Role in Periodontal and Pulpal Regeneration." Journal of Medical Science And clinical Research 05, no. 05 (May 28, 2017): 22447–52. http://dx.doi.org/10.18535/jmscr/v5i5.190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Platelet-rich fibrin"

1

Peck, M. Thabit. "The effect of storage time on the platelet concentration of Choukroun's platelet rich fibrin (PRF)." University of the Western Cape, 2011. http://hdl.handle.net/11394/5219.

Full text
Abstract:
Magister Chirurgiae Dentium (MChD)
Wound healing is a complex process characterised by the repair and reconstitution of lost or damaged tissue. By the mid 1990s, several methods were proposed to enhance wound healing of surgical sites by introducing high concentrations of human platelets to these areas. In the early 21st century, Choukroun et al (2006b) introduced a new type of platelet concentrate that was devoid of any additives, and required no specialised equipment for its production. This concentrate was termed Platelet-rich fibrin (PRF) and although various aspects of this biomaterial had been studied, very little is currently known about its storage properties. Aim: To determine whether storage time had a significant effect on the platelet concentration of Choukroun’s PRF Method: A total of 30 patients were enrolled into the study. Three blood samples of 10ml each were drawn from each patient. Two of the blood samples (Group A and Group B) were centrifuged to form PRF. The third sample was used to measure the baseline blood platelet concentration and was therefore not centrifuged. After PRF had formed in both test groups, it was removed from the test tubes at 2 different times i.e. immediately after centrifuge (Group A) or after 60 min of storage in the blood collecting tube (Group B). The remaining blood was then tested for platelet concentration and compared to each other and the baseline reading. Results: 14 males and 16 females participated in the study (average age 41.7 years). A mean blood platelet concentration of 282.8 ± 58.3 × 109/L was recorded for the baseline reading. Group A had a mean blood platelet concentration 7.9 ± 3.03 × 109/L. Group B had a mean blood platelet concentration of 4.0 ± 1.93 × 109/L. A statistically significant difference was seen between Groups A and B (p < 0.0001). Conclusions: Storage time has a significant effect of the platelet concentration of PRF. If stored over a period of 60 min, the platelet concentration of PRF increases. Further research is required to determine whether this finding is clinically significant.
APA, Harvard, Vancouver, ISO, and other styles
2

Dohan, David. "Platelet Rich Fibrin (PRF) : modèle théorique et études préliminaires." Paris 5, 2005. http://www.theses.fr/2005PA05M004.

Full text
Abstract:
Le PRF (Platelet Rich Fibrin) est un adjuvant chirurgical issu des technologies des colles de fibrine et des concentrés plaquettaires autologues de première génération (les PRP). L'objectif de ce travail est de réaliser une synthèse historique et technologique de cette famille d'adjuvants chirurgicaux à base de fibrine, de tenter de déterminer un premier modèle théorique de l'architecture moléculaire du PRF et enfin, à l'aide d'observations cliniques et d'analyses histologiques, d'évaluer le potentiel cicatriciel du PRF au niveau des tissus mous ainsi qu'au cours de la maturation des greffes osseuses
PRF (Platelet Rich Fibrin) is a surgical additive coming from the autologous fibrin adhesives and first generation platelet concentrates (PRP) technologies. The objective of this work is to make a historical and technological synthesis of this family of fibrin related surgical additives, to create a first theoretical model of the PRF molecular architecture and finally, with clinical observations and histological analysis, to evaluate the healing potential of the PRF in soft tissue wounds and during bone graft maturation
APA, Harvard, Vancouver, ISO, and other styles
3

Hasan, Fadi K. "Characterization of Leukocyte-Platelet Rich Fibrin, a Novel Biomaterial." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/3749.

Full text
Abstract:
Autologous platelet concentrates represent promising innovative tools in the field of regenerative medicine and are successfully used in oral surgery. Several commercial systems exist that generate various forms of platelet concentrates including Platelet-rich plasma (PRP) and Platelet-rich fibrin (PRF). The alpha- granules of entrapped platelets release a variety of peptide growth factors that promotes healing. Usually PRP is a suspension that can be injected into the site of injury or used as a gel with the addition of thrombin (PRP-gel). In contrast Choukroun’s L-PRF is a dense fibrin based biomaterial enriched with platelets and growth factors. The physical state of these natural biomaterials especially L-PRF permits manual handling and suturing onto the tissue bead to improve healing. However, our knowledge about the mechanical characteristic of L-PRF is quite limited and a good understanding of material properties will enable expansion of current clinical applications. This study demonstrates the techniques to identify L-PRF’s mechanical properties (uniaxial tensile testing and suture retention strength); morphology (scanning electron microscope); biological stability and cytocompatibility.
APA, Harvard, Vancouver, ISO, and other styles
4

Barona, Intriago Maria Fernanda. "Regulation of gingival fibroblast gene expression by leukocyte and platelet rich fibrin." Thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62647.

Full text
Abstract:
Objectives: Leukocyte and Platelet-Rich Fibrin (L-PRF), a new clinically used blood product, is rich in leukocytes and platelets embedded in a high-density fibrin network. L-PRF has shown some clinical promise to promote gingival wound healing. In gingival surgeries where L-PRF is being used, it will be in direct contact with human gingival fibroblasts (HGFs) of the surgical flap. However, little is known about the combined effects of the growth factors and cells present in L-PRF on HGFs. We hypothesized that L-PRF regulates expression of key wound healing genes in HGFs. Thus, our aim was to investigate the effects of soluble biological factors released from L-PRF on HGF gene expression. Methods: L-PRF membranes were produced from blood samples of six volunteer donors using standard clinical protocol. The membranes were placed into upper compartments of transwell plate inserts (0.4 µm pore size) with confluent layers of HGFs at the bottom of the wells. Thus, only soluble mediators were able to influence HGF gene expression. HGFs with the L-PRF membranes in the wells were incubated for 48h followed by isolation of total RNA for real-time quantitative PCR of wound healing related genes. The levels of selected proteins produced by the cells were analyzed using Western blotting. Results: Among the 86 genes studied, the expression of 35 genes (41%) was significantly regulated by the L-PRF membranes in HGFs. Replicate membranes from the same donor or between different donors produced similar responses, with membranes from different individuals varying somewhat in magnitude of the response. Among the most regulated genes, matrix metalloproteinase-1 (MMP-1) and MMP-3 showed several-fold increase by L-PRF-treatment, both at the mRNA and protein level. Angiogenesis related genes, VEGF-α and FGF-2 showed also significant up-regulation in HGFs by the L-PRF-treatment. Conclusions: The results demonstrate that the L-PRF membranes have a strong and a specific regulatory effect on HGFs that may modulate several aspects of wound healing.
Dentistry, Faculty of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
5

Peck, Mogammad Thabit. "An analysis of the morphological and biological properties of a novel human leukocyte- and platelet- rich concentrate." University of the Western Cape, 2018. http://hdl.handle.net/11394/6841.

Full text
Abstract:
Philosophiae Doctor - PhD
Wound healing is a complex process that involves several overlapping and interacting biological pathways. The consequences of delayed or abnormal wound healing may result in tissue formation that has impaired function or structural abnormalities. As a result, clinicians have sought ways to enhance this process. Recently, the use of autologous platelet concentrates have become popular in the management of wound healing sites. However, controversy exists as to how these biomaterials should be prepared and applied. We therefore sought to investigate whether a biologically viable and clinically effective platelet concentrate could be prepared using standard laboratory equipment. The findings are presented in a series of articles that have been published in peer-reviewed journals. The results suggest that the experimental platelet concentrate produced, has a morphological structure that consists of a dense fibrin network intermingled with platelets, has the ability to accelerate cellular growth in-vitro, has no adverse effects on cells in-vitro, can concentrate and release a systemically ingested antibiotic over a period of 24 hours in-vitro, can be stored for at least 60 minutes without showing signs of deterioration, and has shown clinical evidence of accelerating wound healing in sinus augmentation and alveolar ridge preservation procedures. The reduced cost of producing such a biomaterial allows it to be available to resource poor settings and to wider range of healthcare providers as compared to standard platelet concentration techniques. Further studies are required to investigate the clinical potential of this promising biomaterial.
APA, Harvard, Vancouver, ISO, and other styles
6

Bhamjee, Feheem. "The in vitro antimicrobial activity of advanced platelet rich fibrin (A-PRF) against microorganisms of the oral cavity." University of the Western Cape, 2017. http://hdl.handle.net/11394/6232.

Full text
Abstract:
Magister Chirurgiae Dentium - MChD (Oral Medicine and Periodontics)
In recent years, the development and use of autologous platelet rich concentrates (PC's) has gained traction within the rapidly progressive, multidisciplinary field of regenerative medicine. A PC subtype, marketed as advanced platelet rich fibrin (A- PRF), is a recent advancement of the original PRF protocol and promoted as a "blood concentrate" containing platelets, leukocytes, circulating stem cells and endothelial cells. A-PRF in the form of membranes, plugs, or even shredded particulates are increasingly being used as surgical adjuncts in areas of previous infection or left exposed within the microbial rich oral environment. Although recent literature has noted the biologic benefits of this material within the context of wound healing and regeneration, the antimicrobial potential of APRF has remained unexplored. The aim of this investigation is to determine if A-PRF displays antimicrobial activity against microbes of the oral cavity with a null hypothesis that its activity is no different to a clot of unprocessed venous blood. Methodology: A-PRF and whole blood samples were obtained from consenting individuals and utilised to conduct an in-vitro agar disk diffusion investigation to determine their antimicrobial activity. Standardised samples of A-PRF, unprocessed clotted blood and 0.2% chlorhexidine gluconate (CHX) were tested against organisms cultured from fresh oral rinse samples and pure cultures of candida albicans, streptococcus mutans, staphylococcus aureus and enterococcus faecalis. The antimicrobial activity was assessed in accordance to the established principles of the agar disk diffusion method and measurement of inhibition zones. Results: A-PRF displayed antimicrobial activity against all of the individual organisms tested within this study following a 24 hour incubation period. However, no significant differences were noted between A-PRF and a natural clot of blood when tested against cultures of the oral rinse sample. Finally, the antimicrobial activity of A-PRF is significantly inferior to an equal volume of the CHX preparation. Conclusion: Although A-PRF displays antimicrobial activity; its strength, spectrum and biologic activity within a polymicrobial environment requires further investigation.
APA, Harvard, Vancouver, ISO, and other styles
7

Zhu, Christina Zhen Chao. "The effect of leucocyte and platelet-rich fibrin (L-PRF) on healing of bone defects in dogs." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/18851.

Full text
Abstract:
Objective: To evaluate and compare healing between L-PRF, cancellous bone graft(BG) and L-PRF and BG(BOTH) on the gap created during tibial tuberosity advancement procedure(TTA). Study Design: Prospective clinical study involving dogs treated with TTA (n=36). Hypothesis: The first hypothesis was that L-PRF could be used in dog long bones without causing clinically evident complications. The second hypothesis was that bone defects filled with BOTH would heal faster than those filled with BG alone. Material and Methods: Dogs underwent TTA at the University Veterinary Teaching Hospital Sydney via a technique using a tension-band plate. Ethics approval was obtained from the USYD AEC approval number 2013/5993. Consent was established prior to study inclusion however owners were blinded to treatment group (TG). TGs had osteotomy filled with L-PRF, BG or BOTH. A total of 36 stifles from 35 dogs met the inclusion criteria. Post-op radiographs from 2, 4 and 6weeks were graded using a 0-4 point scale. Computed tomography(CT) was also performed at 6weeks to assess bone healing. Logistic regression analysis was done to look at assessment parameters and the effect of TGs on osteotomy healing. Results: There was no effect of TG or time on rate of complications. There was no statistical significance between BG and BOTH groups except the proximal healing for the BOTH group was 2.49 times more likely to have a higher score than BG. BOTH scored significantly higher than L-PRF except for proximal healing (no difference). There was no effect of differing radiologists assessment on osteotomy fill, or TG on the mean Hounsfield Units at location ½ and ⅓ of the way distal to the cage. Conclusion: This study has demonstrated that L-PRF is a viable product for TTA resulting in successful bone healing. Healing at the proximal site using BG is the same as L-PRF based on radiographs. CT analysis suggests that the effect of L-PRF on bone healing is comparable to BG at 6 weeks post TTA.
APA, Harvard, Vancouver, ISO, and other styles
8

Glazier, Thomas F., Thomas C. Waldrop, John C. Gunsolley, and Robert Sabatini. "The Role of Leukocyte-Platelet Rich Fibrin in Human Alveolar Ridge Preservation: A Randomized Clinical Trial." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/3735.

Full text
Abstract:
PURPOSE: The aim of this study is to examine the healing of intact extraction sockets grafted with leukocyte-platelet rich fibrin (L-PRF) as compared to sockets grafted with freeze-dried bone allograft (FDBA) and a resorbable collagen barrier membrane (RCM). METHODS: This prospective randomized, examiner blinded pilot study included 17 subjects randomized to two treatment groups. Serum total cholesterol, low density lipoprotein (LDL), 25-hydroxyvitamin-D3, and platelet counts were determined preoperatively in all subjects. The experimental arm consisted of 8 posterior tooth-bounded intact extraction sites receiving L-PRF plugs. The control group consisted of 9 posterior tooth-bounded intact extraction sites receiving FDBA and RCM. An acrylic stent was fabricated to take duplicate clinical and CBCT measurements immediately post-extraction and at time of implant placement. A repeat-measures analysis of variance was utilized for statistical analysis. RESULTS: The study failed to detect a clinical or radiographic difference between treatment groups in horizontal or vertical ridge dimension changes. Serum cholesterol, LDL, 25-hydroxyvitamin-D3, and buccal plate thickness had a non-significant effect on outcome measurements, although there was a high prevalence of hyperlidpidemia and hypovitaminosis in the study population. CONCLUSIONS: The alveolar ridge dimension changes in intact posterior extraction sockets may be similar when either L-PRF or FDBA and RCM are utilized as socket grafting material. Although there was a high prevalence of high cholesterol and low 25-hydroxyvitamin-D3 levels in the population, this study failed to detect a significant correlation between preoperative serum levels and postoperative ridge dimension changes.
APA, Harvard, Vancouver, ISO, and other styles
9

MURGIA, Denise. "NEW GUIDED BONE REGENERATION PROCEDURE USING LEUKOCYTE AND PLATELET RICH FIBRIN (L PRF) IN ORAL SURGERY." Doctoral thesis, Università degli Studi di Palermo, 2021. http://hdl.handle.net/10447/500658.

Full text
Abstract:
Non-transfusional hemocomponents are autogenous products used in several surgical fields obtained by the centrifugation of a blood sample from a patient and able to promote hard and soft tissue regeneration, local haemostasis, and the acceleration of wound healing. The aim of this PhD thesis was the validation of an innovative protocol for the Guided Bone Regeneration (GBR) technique using second-generation autologous platelet concentrates, Leukocytes and Platelet-rich Fibrin (L-PRF), in post-extraction sockets of patients in need of dental avulsions and successive implant prosthetic rehabilitation, evaluating its ability to prevent alveolar bone resorption and promote bone regeneration. The secondary aim was the design and development of a multicomposite loaded with antimicrobic and antioxidant agents, to be applied wrapped in the L-PRF membrane, enhancing its regenerative properties. This project cohering with the National Operational Program (PON) “Research and Innovation” (R&I) 2014-2020 funding by the Italian Ministry of Education, University and Research, aimed to promote the research and the innovation of the country, with a particular interest on the Health Specialization Area.
APA, Harvard, Vancouver, ISO, and other styles
10

Schuldt, Luisa Antonia. "In vitro evaluation of the effects of leukocyte-platelet rich fibrin on disinfection of a rough implant surface." Thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62613.

Full text
Abstract:
Objectives: Peri-implantitis is a frequent and serious clinical problem affecting between 1 and 47% of implants. Bacterial contamination of the roughened implant surface plays a major role in the etiology and progression of the disease. Successful treatment of peri-implantitis requires disinfection of the rough implant surface. There is no generally accepted protocol for implant disinfection. Autologous leukocyte and platelet-rich fibrin (L-PRF) membranes can be produced from autologous human blood via a one-step centrifugation procedure. It was hypothesized that the antimicrobial defense system of L-PRF may decontaminate the SLAⓇ implant surface. The objective of this study was to test the efficacy of L-PRF for SLAⓇ implant surface disinfection. Methods: Collagen-coated SLAⓇ (sand blasted, large grit acid etched) titanium discs were inoculated with dispersed dental plaque with a minimum bacterial cell concentration of 3.2 × 10⁷ CFU/ml. After 21 days of anaerobic incubation at 37C, discs were rinsed with 12 ml 0.9% NaCl to remove unattached biofilm, and exposed for 48 hours to Leukocyte-Platelet Rich Fibrin (L-PRF) in DMEM. Disks with or without rinsing with 12 ml of 0.9 % NaCl were fixed for SEM. Bacterial counts and perforations in bacteria were quantified from standardized scanning electron micrographs of the implant surface. The rinsing solution was collected and Western blot analysis was performed. L-PRF disks were compared with the control group (rinse). Results: Difference in presence of bacteria displaying perforation of the cell wall between cell–rich L-PRF treated samples and rinsed control group was statistically significant (p < 0.0001, Fisher's Exact Test). Western blot analysis of the rinse fluid demonstrated presence of Platelet Factor-4. Activated platelets in intimate contact with bacteria were detected on SEM images. SEM analysis demonstrated a statistically significant reduction of residual bacteria in the lacunae of the rough SLAⓇ surface after L-PRF treatment. (p< 0.05, Kruskal-Wallis). Conclusions: Autologous L-PRF may have potential as a biological means to decontaminate rough implant surfaces, possibly by exploiting the antimicrobial effects of platelets.
Dentistry, Faculty of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Platelet-rich fibrin"

1

Miron, Richard J., and Joseph Choukroun, eds. Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Miron, Richard J. Understanding Platelet-Rich Fibrin. Quintessence Publishing Company, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gupta, Kanishk, Siddharth Mehta, and Vani Taneja. Platelet Rich Fibrin And Periodontal Tissue Regeneration. LAP Lambert Academic Publishing, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sabeti, Mohammad. Platelet-Rich Fibrin Prf Applications in Endodontics. Quintessence Publishing Company, Incorporated, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Khan, Aamer. Regenerative Medicine in Aesthetic Treatments: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin. Taylor & Francis Group, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Khan, Aamer. Regenerative Medicine in Aesthetic Treatments: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin. Taylor & Francis Group, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khan, Aamer. Regenerative Medicine in Aesthetic Treatments: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin. Taylor & Francis Group, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Khan, Aamer. Regenerative Medicine in Aesthetic Treatments: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin. CRC Press LLC, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Khan, Aamer. Regenerative Medicine in Aesthetic Treatments: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin. CRC Press, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miron, Richard J., and Joseph Choukroun. Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications. Wiley & Sons, Limited, John, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Platelet-rich fibrin"

1

Tran, Alison, and Deanne Mraz Robinson. "Platelet-Rich Fibrin Matrix." In Aesthetic Clinician's Guide to Platelet Rich Plasma, 97–105. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-81427-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khan, Aamer. "Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF)." In Regenerative Medicine in Aesthetic Treatments, 61–66. London: CRC Press, 2021. http://dx.doi.org/10.1201/9781003001478-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Choukroun, Joseph, and Richard J. Miron. "Platelet Rich Fibrin: A Second-Generation Platelet Concentrate." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 1–14. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Miron, Richard J., and Joseph Choukroun. "Future Research with Platelet Rich Fibrin." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 251–61. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miron, Richard J., Michael A. Pikos, Yufeng Zhang, and Tobias Fretwurst. "Guided Bone Regeneration with Platelet Rich Fibrin." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 159–83. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gluckman, Howard. "Platelet Rich Fibrin as an Adjunct to Implant Dentistry." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 145–57. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shahi, Apra, and Apoorva Mishra. "Homologous Platelet-Rich Plasma and Leucocyte–Platelet-Rich Fibrin as a Regenerative Therapy for Corneal Ulcers." In Springer Protocols Handbooks, 459–76. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2425-8_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nacopoulos, Cleopatra. "Use of Platelet Rich Fibrin in Facial Aesthetics and Rejuvenation." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 215–35. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Miron, Richard J., and Joseph Choukroun. "Use of Platelet Rich Fibrin in Other Areas of Medicine." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 237–49. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miron, Richard J., Giovanni Zucchelli, and Joseph Choukroun. "Uses of Platelet Rich Fibrin in Regenerative Dentistry: An Overview." In Platelet Rich Fibrin in Regenerative Dentistry: Biological Background and Clinical Indications, 47–57. Oxford, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119406792.ch4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Platelet-rich fibrin"

1

Nica, Diana, Emilia Ianes, and Marius Pricop. "Platelet rich fibrin in jaw defects." In Sixth International Conference on Lasers in Medicine, edited by Darinca Carmen Todea, Adrian G. Podoleanu, and Virgil-Florin Duma. SPIE, 2016. http://dx.doi.org/10.1117/12.2189921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Medeiros, Flávio Augusto Oliveira de, Flávia Patrícia Sena Teixeira Santos, Sílvia Lovine Kobata, Lucas Moyses Carvalho de Oliveira, João Pedro de Matos Assunção, Rafael Fusaro Aguiar Oliveira, and Matheus Tozatto Baptista Coelho Leal. "Treatment of rheumatoid vasculitis ulcer with Platelet Rich Fibrin." In XXXIX Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2022. http://dx.doi.org/10.47660/cbr.2022.2147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taufik S, Ahmad, Adnanto Wiweko, Devi Rahmadona, Dyah Purnaning, Mohammad Rizki, and Bayu Tirta Dirja. "Cell Multiplication in Platelet Rich Fibrin (PRF) and Platelet Rich Plasma (PRP) as Biofuels for Cartilage Tissue Engineering." In 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/ahsr.k.220206.062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Che, Yuanqian, Peirong Li, Li Tian, Menghan Wang, Rongfeng Xiong, Xue Lei, Xinhui Li, and Zhenlin Ge. "The Research Progress of Platelet-Rich Fibrin Applications in the Orthodontic Treatment." In 2016 7th International Conference on Education, Management, Computer and Medicine (EMCM 2016). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/emcm-16.2017.99.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bhadra, Primadhanty, Indah Julianto, Mardiana, Adniana Nareswari, Halim Perdana, and Endra Yustin Ellista Sari. "The Efficacy of Platelet-rich Plasma Combined with Platelet-rich Fibrin in the Treatment of Multiple Chronic Venous Leg Ulcer: A Case Report." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008160905100513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cohen, I., and J. G. White. "DIFFERENT SITES FOR FIBRINOGEN AND FIBRIN RECEPTORS ON PLATELETS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643521.

Full text
Abstract:
Platelet stickiness and aggregation depend on availability of surface membrane glycoprotein Ilb-IIIa complex to bind fibrinogen. The development of isometric tension in platelet-rich clots is a manifestation of fibrin binding to the cells as well as platelet contractile activity. The possibility that fibrinogen and fibrin may bind to different portions of the GPIIb-IIIa complex has apparently not been considered. In order to determine whether the receptors for the fibrinogen and fibrin on the GPIIb-IIIa complex are identical, we investigated the effect of various monoclonal antibodies to the Ilb-IIIa complex and the tetrapeptide Arg-Gly-Asp-Ser (RGDS), a recognition site on fibrinogen for IIb-IIIa, on the development of isometric tension and ultrastructure of platelet-fibrin clots. Monoclonal antibodies A2A6 and 7E3 decreased the maximal tension, as well as the rate of tension development. Platelets and fibrin were oriented longitudinally in antibody treated clots, but the concentrations of fibrin and platelet aggregates determined by morphometry were significantly reduced. T10 and 10E5 increased tension, while AP2 and PAC1 had no substantial effect. Increasing concentrations of RGDS from 62.5 pM to 500 pM resulted in greater maximal tension and rate of tension development, reaching a five-fold increase when 500 pM RGDS was used. RGDS did not affect the Mg-stimulated platelet actomyosin ATPase activity. Morphometry revealed increased concentrations of oriented fibrin and platelet aggregates in RGDS-treated clots. Results of this study confirm the different topography of the epitopes on the Ilb-IIIa complex and provide evidence for different receptor sites for fibrinogen and fibrin on the IIb-IIIa complex
APA, Harvard, Vancouver, ISO, and other styles
7

White, James G., and Isaac Cohen. "DISTRIBUTION OF INTRAMEMBRANOUS PARTICLES (IMP) ON PLATELETS IN CLOTS UNDER ISOMETRIC TENSION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643537.

Full text
Abstract:
Development of isometric tension in platelet-rich clots is a manifestation offibrin binding to the cells, as well as to platelet contractile activity. However, the nature of the platelet-fibrin association through which the force of contraction is transmitted remains unknown. A previous report suggested that clustering of the intramembranous particles (IMP) visible in replicas of freeze-fractured platelets in clots might represent sites of fibrin attachment and force transduction across the platelet membrane. In the present study platelet clots were prepared at various stages during development of isometric tension. Clots fixed in glutaraldehyde were combined with osmic acid and further processed for thin sections, or with glycerol, frozen in liquid nitrogen and freeze-fractured in a Balzer's device. Thin sections revealed the longitudinal orientation of platelets and fibrin strands in the long axis of tension. Close associations between fibrin strands and extended portions of platelets were readily identified. However, no clearly discernible repetitive associations could be identified. Replicas of freeze fractured platelet clots under isometric tension revealed aspects of fibrin strands substructure and the platelet secretory pathway. However, no specific associations between fibrin and IMP were apparent. The usual 2 to 1 ratio of IMP on the inside of the outer layer (E face) compared to the outside of the interior layer (P face) of resting platelets was preserved on thrombin activated platelets in isometric clots. No evidence of IMP clustering could be identified. Experiments to identify the origin of IMP clustering revealed it occurred only on severely damaged platelets. Thus, clustering of IMP in replicas of freeze fractured platelets does not appear related to fibrin binding to platelets or to transduction of contractile force from the interior of the platelet to fibrin strands and the development of tension in isometric clots.
APA, Harvard, Vancouver, ISO, and other styles
8

Betaubun, Ance Imelda, Etty Farida, Anggana Rafika Paramitasari, Willa Damayanti, Susanti Rosmala Dewi, Moerbono Mochtar, and Indah Julianto. "The Combination Therapy of Microneedling and Subcision with Platelet Rich Plasma (PRP) versus Platelet Rich Fibrin Matrix (PRFM) on Rolling and Boxscar Type Acne Scar: Case Series." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008157703730376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pratama, Gita, Budi Wiweko, Normalina Sandora, Evanti Kusumawardhani, Deniswari Rahayu, Kamila Puspita, and Mirta H. Reksodiputro. "Cito-compability analysis of mesenchymal stem cells in platelet rich fibrin matrix (PRFM) for tissue regeneration." In THE 4TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2019. AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5139322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Harre, J., R. Allaferdov, S. R. O. Stolle, T. Lenarz, and A. Warnecke. "Comparison of platelet-rich plasma and fibrin with regard to their neuroprotective effect on spiral ganglion neurons." In 100 JAHRE DGHNO-KHC: WO KOMMEN WIR HER? WO STEHEN WIR? WO GEHEN WIR HIN? Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1728453.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Platelet-rich fibrin"

1

Silva, Igor Iuco Castro da. Platelet-Rich Fibrin: A Versatile Purpose for Alveolar Ridge Preservation. Science Repository, July 2019. http://dx.doi.org/10.31487/j.dobcr.2019.03.05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Moraschini, Vittorio, Richard Miron, and Anton Sculean. Use of Platelet-Rich Fibrin for the treatment of intrabony and furcation defects: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meza-Mauricio, Jonathan, Camila Pinheiro Furquim, Antonella Geldres, Gerardo Mendoza-Azpur, Belen Retamal-Valdes, and Marcelo Faveri. Is the use of platelet rich fibrin effective in the healing, pain and control of post-operative bleeding of palatine area after harvesting free gingival graft? A systematic review of randomized clinical studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Meza-Mauricio, Jonathan, Camila Pinheiro Furquim, Antonella Geldres, Gerardo Mendoza- Azpur, Belen Retamal-Valdes, Vittorio Moraschini, and Marcelo Faveri. Is the use of platelet rich fibrin effective in the healing, pain and control of post-operative bleeding of palatine area after harvesting free gingival graft? A systematic review of randomized clinical studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0113.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Platelet-rich fibrin' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography